Last updated on March 2019

A Randomized Double-blind Multi-center Multi-national Trial to Evaluate the Efficacy Safety and Immunogenicity of SAIT101 Versus Rituximab as a First-line Immunotherapy Treatment in Patients With Low Tumor Burden Follicular Lymphoma


Contact Investigators or Research Sites near you

Start Over

Research site

Whittier, CA United States

Research Site

Canberra, Australia

Research site

Temuco, Chile

Research site

Hradec Kralove, Czechia

Research site

Praha, Czechia

Reasearch site

Praha, Czechia

Research site

Libourne Cedex, France

Research site

Poitiers, France

Research site

Hamburg, Germany

Research site

Budapest, Hungary

Research site

San Giovanni Rotondo, Italy

Research site

Terni, Italy

Research site

Busan, Korea, Republic of

Research site

Seoul, Korea, Republic of

Research site

Mexico City, Mexico

Research site

Pretoria, South Africa

Research site

L'Hospitalet de Llobregat, Spain

Research site

Madrid, Spain

Research site

Ankara, Turkey

Research site

Istanbul, Turkey

Research site

Mersin, Turkey

Research site

Samsun, Turkey

Research site

Norwich, United Kingdom

Research site

Cádiz, Spain

Recruitment Status: Closed


Brief Description Eligibility Contact Research Team


Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.